Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2019-04-24 2019-04-03
Drug Identification Number 02237792 02237792
Brand name AVAXIM AVAXIM
Common or Proper name Hepatitis A Vaccine Inactivated Hepatitis A Vaccine Inactivated
Company Name SANOFI PASTEUR LIMITED SANOFI PASTEUR LIMITED
Ingredients HEPATITIS A VACCINE, INACTIVATED HEPATITIS A VACCINE, INACTIVATED
Strength(s) 160UNIT 160UNIT
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 x 0.5 mL (single dose) syringe 1 x 0.5 mL (single dose) syringe
ATC code J07BC J07BC
ATC description VIRAL VACCINES VIRAL VACCINES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2019-07-01 2019-07-01
Actual start date 2019-04-24
Estimated end date 2019-08-01 Unknown
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments There is an anticipated increase in the private market demand for AVAXIM® due to a prolonged shortage of other Hepatitis A vaccines in the Canadian market. There is an anticipated increase in the private market demand for AVAXIM® due to a prolonged shortage of other Hepatitis A vaccines in the Canadian market.
Health Canada comments